DAWN – Day One Biopharmaceuticals, Inc.
Float Short %
13.37
Margin Of Safety %
Put/Call OI Ratio
0.41
EPS Next Q Diff
0.05
EPS Last/This Y
0.05
EPS This/Next Y
0.48
Price
11.8
Target Price
23.12
Analyst Recom
1.22
Performance Q
37.46
Upside
-542.7%
Beta
-1.27
Ticker: DAWN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | DAWN | 11.95 | 0.38 | 0.17 | 51905 |
| 2026-01-26 | DAWN | 12.03 | 0.38 | 0.02 | 53478 |
| 2026-01-27 | DAWN | 12.34 | 0.37 | 0.04 | 53939 |
| 2026-01-28 | DAWN | 11.77 | 0.37 | 0.05 | 54208 |
| 2026-01-29 | DAWN | 11.15 | 0.37 | 0.75 | 54541 |
| 2026-01-30 | DAWN | 11.16 | 0.37 | 0.09 | 55224 |
| 2026-02-02 | DAWN | 11.52 | 0.37 | 0.76 | 55410 |
| 2026-02-03 | DAWN | 11.18 | 0.38 | 1.65 | 56699 |
| 2026-02-04 | DAWN | 10.75 | 0.38 | 0.49 | 56872 |
| 2026-02-05 | DAWN | 10.49 | 0.38 | 0.00 | 58615 |
| 2026-02-06 | DAWN | 11.41 | 0.42 | 0.02 | 54494 |
| 2026-02-09 | DAWN | 11.73 | 0.42 | 0.06 | 54553 |
| 2026-02-10 | DAWN | 11.43 | 0.42 | 0.01 | 54465 |
| 2026-02-11 | DAWN | 11.23 | 0.42 | 0.02 | 54515 |
| 2026-02-12 | DAWN | 11 | 0.42 | 0.00 | 54576 |
| 2026-02-13 | DAWN | 11.36 | 0.42 | 0.14 | 54664 |
| 2026-02-17 | DAWN | 11.89 | 0.42 | 0.02 | 54745 |
| 2026-02-18 | DAWN | 11.56 | 0.41 | 0.04 | 55151 |
| 2026-02-19 | DAWN | 12.09 | 0.41 | 0.65 | 55357 |
| 2026-02-20 | DAWN | 11.81 | 0.41 | 1.04 | 55552 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | DAWN | 11.95 | 72.6 | - | -0.97 |
| 2026-01-26 | DAWN | 12.03 | 72.6 | - | -0.97 |
| 2026-01-27 | DAWN | 12.34 | 72.6 | - | -0.97 |
| 2026-01-28 | DAWN | 11.78 | 72.6 | - | -0.97 |
| 2026-01-29 | DAWN | 11.15 | 72.6 | - | -0.97 |
| 2026-01-30 | DAWN | 11.15 | 72.6 | - | -0.97 |
| 2026-02-02 | DAWN | 11.51 | 72.6 | - | -0.97 |
| 2026-02-03 | DAWN | 11.17 | 72.6 | - | -0.97 |
| 2026-02-04 | DAWN | 10.74 | 72.6 | - | -0.97 |
| 2026-02-05 | DAWN | 10.49 | 72.6 | - | -0.97 |
| 2026-02-06 | DAWN | 11.40 | 72.6 | - | -0.97 |
| 2026-02-09 | DAWN | 11.73 | 75.6 | - | -0.97 |
| 2026-02-10 | DAWN | 11.41 | 75.6 | - | -0.97 |
| 2026-02-11 | DAWN | 11.23 | 75.6 | - | -0.97 |
| 2026-02-12 | DAWN | 11.01 | 75.6 | - | -0.97 |
| 2026-02-13 | DAWN | 11.37 | 75.6 | - | -0.97 |
| 2026-02-17 | DAWN | 11.90 | 75.7 | - | -0.97 |
| 2026-02-18 | DAWN | 11.57 | 75.7 | - | -0.97 |
| 2026-02-19 | DAWN | 12.06 | 75.7 | - | -0.97 |
| 2026-02-20 | DAWN | 11.80 | 76.0 | - | -0.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | DAWN | -0.19 | -0.01 | 14.74 |
| 2026-01-26 | DAWN | -0.19 | 0.23 | 14.74 |
| 2026-01-27 | DAWN | -0.19 | 0.23 | 14.74 |
| 2026-01-28 | DAWN | -0.19 | 0.23 | 15.00 |
| 2026-01-29 | DAWN | -0.19 | 0.23 | 15.00 |
| 2026-01-30 | DAWN | -0.19 | 0.23 | 15.00 |
| 2026-02-02 | DAWN | -0.19 | 0.19 | 15.00 |
| 2026-02-03 | DAWN | -0.19 | 0.19 | 15.00 |
| 2026-02-04 | DAWN | -0.19 | 0.19 | 15.00 |
| 2026-02-05 | DAWN | -0.19 | 0.19 | 15.00 |
| 2026-02-06 | DAWN | -0.19 | 0.19 | 15.00 |
| 2026-02-09 | DAWN | -0.19 | 1.23 | 15.00 |
| 2026-02-10 | DAWN | -0.19 | 1.23 | 15.00 |
| 2026-02-11 | DAWN | -0.19 | 1.23 | 13.49 |
| 2026-02-12 | DAWN | -0.19 | 1.23 | 13.49 |
| 2026-02-13 | DAWN | -0.19 | 1.23 | 13.49 |
| 2026-02-17 | DAWN | -0.19 | 2.07 | 13.33 |
| 2026-02-18 | DAWN | -0.32 | 2.07 | 13.33 |
| 2026-02-19 | DAWN | -0.32 | 2.07 | 13.37 |
| 2026-02-20 | DAWN | -0.22 | 2.07 | 13.37 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.2
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
-0.22
Institutional Transactions
2.07
Beta
-1.27
Average Sales Estimate Current Quarter
44
Average Sales Estimate Next Quarter
52
Fair Value
Quality Score
39
Growth Score
26
Sentiment Score
78
Actual DrawDown %
58.9
Max Drawdown 5-Year %
Target Price
23.12
P/E
Forward P/E
PEG
P/S
9.32
P/B
2.68
P/Free Cash Flow
EPS
-1.49
Average EPS Est. Cur. Y
-0.97
EPS Next Y. (Est.)
-0.5
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-113.53
Relative Volume
0.53
Return on Equity vs Sector %
-62.7
Return on Equity vs Industry %
-45.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.21
EBIT Estimation
Day One Biopharmaceuticals, IncSector: Healthcare
Industry: Biotechnology
Employees: 184
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading